4//SEC Filing
MAKO Surgical Corp. 4
Accession 0001209191-08-058448
CIK 0001411861operating
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 6:20 PM ET
Size
14.2 KB
Accession
0001209191-08-058448
Insider Transaction Report
Form 4
BRUNK GERALD A
Director
Transactions
- Purchase
Common Stock Warrants (right to buy)
2008-10-31$0.13/sh+23,854$2,982→ 23,854 total(indirect: By IRA)Exercise: $7.44From: 2009-04-29Exp: 2015-11-02→ Common Stock (23,854 underlying) - Purchase
Common Stock
2008-10-31$6.20/sh+42,020$260,524→ 410,260 total(indirect: By IRA) - Purchase
Common Stock
2008-10-31$6.20/sh+119,270$739,474→ 1,164,458 total(indirect: By IRA) - Purchase
Common Stock Warrants (right to buy)
2008-10-31$0.13/sh+8,404$1,051→ 8,404 total(indirect: By IRA)Exercise: $7.44From: 2009-04-29Exp: 2015-11-02→ Common Stock (8,404 underlying)
Holdings
- 282,685(indirect: By MLII Co-Investment Fund NC Limited Partneship)
Common Stock
Footnotes (3)
- [F1]These shares are owned directly by Lumira Capital I Limited Partnership ("LC I")(formerly known as MDS Life Sciences Technology Fund II NC Limited Partnership). Lumira Capital Management Corp., a subsidiary of Lumira Capital Corp., may be deemed to be the indirect beneficial owner of the shares pursuant to a management agreement with LC I. As the reporting person is the Senior Vice President/Managing Director of Lumira Capital Corp., he may be deemed to be the indirect beneficial owner of these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F2]These shares are owned directly by Lumira Capital I Quebec Limited Partnership, formerly known as MDS Life Sciences Technology Fund II Quebec Limited Partnership ("LCIQ"). Lumira Capital Management Corp., a subsidiary of Lumira Capital Corp., provides services to LCIQ. As the reporting person is the Senior Vice President/Managing Director of Lumira Capital Corp., he may be deemed to be the indirect beneficial owner of these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]These shares are owned directly by MLII Co-Investment Fund NC Limited Partnership ("MLII"). Lumira Capital Management Corp., a subsidiary of Lumira Capital Corp., provides services to MLII. As the reporting person is the Senior Vice President/Managing Director of Lumira Capital Corp., he may be deemed to be the indirect beneficial owner of the shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
MAKO Surgical Corp.
CIK 0001411861
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411861
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 6:20 PM ET
- Size
- 14.2 KB